News

Mickey Janvier Joins 21Shares as Head of North America Sales

Mickey Janvier Joins 21Shares as Head of North America Sales

Mickey Janvier's Leadership Marks a New Chapter for 21Shares

Mickey Janvier brings over ten years of sharp distribution and business development experience to 21Shares, a firm that has steadily built its presence in the U.S. market. As a notable issuer of cryptocurrency exchange-traded products (ETPs), the company is demonstrating continued momentum amid substantial market growth.

Strategic Vision for Expanding Cryptocurrency Reach

Effective immediately, Janvier takes on the role of Head of North America Sales at 21Shares, where he will oversee a transformative distribution strategy across the United States. Reporting directly to CEO Russell Barlow, he will focus on fostering relationships with financial advisors, wealth management platforms, and institutional investors to significantly enhance the firm’s footprint in North America.

Insights from Leadership

Russell Barlow commented on the exciting developments in the U.S. that have seen a surge in crypto adoption. This wave is, in part, due to favorable legislative and regulatory conditions encouraging both retail and institutional investors to delve deeper into the world of cryptocurrencies. Barlow expressed his confidence in Janvier's capabilities, anticipating that under his guidance, 21Shares will continue delivering exceptional support to its clients.

Previous Experience Enhances Potential

Prior to joining 21Shares, Janvier served as Head of Americas Distribution at Perpetual Asset Management, where he successfully spearheaded commercial strategies and growth initiatives tailored for various investment sectors. His vast experience includes a significant tenure at Aberdeen, holding essential leadership positions, including Head of North American Business Development. There, he managed pivotal aspects of a $65 billion enterprise.

Commitment to Client Success

Janvier expressed enthusiasm about joining 21Shares during such a transformative period for crypto ETPs. He highlighted the firm's robust reputation in the crypto investment sector and shared his eagerness to work collaboratively with the team to enhance investor access to these innovative products across the U.S. and beyond.

Impact on Market Dynamics

The strategic addition of Janvier is indicative of 21Shares’ intentional approach to capitalize on the growing dynamics of the U.S. crypto market. The firm's successful launch of spot Bitcoin and Ethereum ETFs further reflects its dedication to providing investors with diversified products in this evolving financial landscape. Currently, 21Shares manages assets exceeding $11 billion and boasts listings on multiple major exchanges, including SIX Swiss Exchange, Nasdaq, and Euronext.

About 21Shares

21Shares AG stands out as a leading provider of cryptocurrency exchange-traded products, proud to offer the largest range of crypto ETPs available. Its inception was rooted in making cryptocurrency more accessible to investors by bridging the gap between traditional and decentralized finance.

Innovative Solutions for Investors

The company made history in 2018 by listing the world’s first physically-backed crypto ETP, establishing a long-standing track record of delivering innovative exchange-traded funds listed on prominent securities exchanges globally. Armed with a thorough research team and advanced technology, 21Shares is committed to providing effective investment solutions that prioritize cost-efficiency.

Frequently Asked Questions

What role will Mickey Janvier play at 21Shares?

Mickey Janvier will serve as the Head of North America Sales, focusing on expanding the firm’s distribution strategy and client relationships in the U.S.

What experience does Janvier bring to this position?

Janvier has over a decade of experience in business development and has held leadership roles at leading firms like Perpetual Asset Management and Aberdeen.

Why is 21Shares focusing on the North American market now?

The firm is responding to a significant rise in cryptocurrency adoption in the U.S., driven by favorable regulatory conditions and increasing investor interest.

How does 21Shares differentiate itself in the cryptocurrency market?

21Shares offers the largest suite of ETPs available, focusing on bridging traditional finance with decentralized finance to make crypto investments accessible.

What recent achievements has 21Shares accomplished?

The firm recently launched its spot Bitcoin and Ethereum ETFs, contributing to a total asset management portfolio exceeding $11 billion.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Propensity Rockets to No. 70 on the 2026 Inc. 5000 List

Updated Category News Views 6

Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...

Continue Reading
Lyric Health's AI System Promises Data-Driven Revolution

Updated Category News Views 5

A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...

Continue Reading
Medicare Competitive Bidding May Slash Jobs, Access

Updated Category News Views 4

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

Continue Reading
Red Banyan Earns Top Honors in Florida for 2026

Updated Category News Views 6

Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...

Continue Reading
Finastra Recognized as 2026 Leader in Payment Platforms

Updated Category News Views 5

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

Continue Reading
Ransoms and Mega-Losses Surge in Cyber Claims Study

Updated Category News Views 5

Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...

Continue Reading
OrthoAtlanta Expands with Dr. Smith's Expertise Hire

Updated Category News Views 4

OrthoAtlanta Welcomes New Orthopedic Surgeon In a world where healthcare organizations are constantly stretching their wings, this new addition of Dr. Carson J. Smith to the fold at Piedmont Orthopedics | OrthoAtlanta stands out. This isn't just some cosmetic face-lift, folks. It's a real investment in the community, not to mention a crucial broadening of what this...

Continue Reading
2026 CEE Awards Highlight Energy Innovation Leaders

Updated Category News Views 7

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

Continue Reading
American Savings Bank IPO Hits NYSE: $129M Raised

Updated Category News Views 8

A Big Day for American Savings Bank Buckled up yet? Because American Savings Bank has just shot onto the NYSE, raising a hefty $129 million. A solid start, I’d say, for a Honolulu-based outfit that now struts around with a valuation tipping beyond $1.03 billion. That’s what you get when you price more than eight million shares at $16 a pop. NYSE:ASBH is the new kid on...

Continue Reading
Koogler's Sale to ALL4: A Game-Changer for the Southeast

Updated Category News Views 6

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Continue Reading

Top 5 Most Recently Viewed Articles

Strategic Boost for Inseego as George Mulhern Joins Board

Updated Category News Views 140

Inseego Welcomes George Mulhern to Its Board of Directors Inseego Corp. (Nasdaq: INSG) is thrilled to announce the appointment of George Mulhern, a distinguished leader in the wireless technology sector, to its Board of Directors. With a profound background in developing and steering wireless tech companies, Mr. Mulhern has most recently held the position of Senior Vice...

Continue Reading
Economic Outlook Raises Concerns of Inflation Under Trump

Updated Category News Views 128

Increased Economic Concerns with Trump's Return Recent findings reveal that economists are increasingly worried about the potential return of former President Donald Trump and its effects on inflation and federal deficits. Survey Findings on Inflation and Economic Policies A survey conducted by a group of economists indicates a majority foresee higher inflation and...

Continue Reading
Join the Class Action Against Rocket Pharmaceuticals Today

Updated Category News Views 134

Join the Class Action Against Rocket Pharmaceuticals Investors are being called to participate in a class action lawsuit concerning Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT). This lawsuit is aimed at recovering losses incurred by shareholders due to alleged securities fraud that impacted the company's financial standing during a specified timeframe. Understanding the...

Continue Reading
Nipocalimab Receives Priority Review from U.S. FDA for gMG

Updated Category News Views 297

Nipocalimab Secures U.S. FDA Priority Review Status Johnson & Johnson (NYSE: JNJ) has exciting news regarding its investigational drug, Nipocalimab. The U.S. Food and Drug Administration (FDA) has granted Priority Review designation for Nisocalimab as a treatment for generalized myasthenia gravis (gMG) in patients with specific autoantibodies. This important milestone...

Continue Reading
Navigating the Canadian Multifamily Landscape: Supply and Demand

Updated Category News Views 89

Understanding Canada's Multifamily Market Trends In recent times, the Canadian multifamily housing market has exhibited some intriguing trends, particularly concerning rent growth and vacancy rates. As highlighted in the latest report from Yardi Canada, the market showcases a scenario where rent growth is slowing, while vacancies remain low. This situation reflects the...

Continue Reading